4//SEC Filing
GRIFFITH MELINDA 4
Accession 0001493152-22-023378
CIK 0001642380other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 8:18 PM ET
Size
8.9 KB
Accession
0001493152-22-023378
Insider Transaction Report
Form 4
GRIFFITH MELINDA
Director
Transactions
- Purchase
Common Stock, no par value
2022-08-16$1.00/sh+10,000$10,000→ 30,000 total - Award
Common Stock, no par value
2022-08-15+10,000→ 20,000 total - Award
Option to Purchase Common Stock
2022-08-15+45,000→ 45,000 totalExercise: $0.97Exp: 2032-08-15→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
- [F2]Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
Documents
Issuer
Oncocyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001783697
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 8:18 PM ET
- Size
- 8.9 KB